Prexige

Canada Bans Anti-Inflammatory Drug Prexige after Reports of Severe Liver Damage

Monday, March 03, 2008 by: David Gutierrez, staff writer
Tags: Prexige, health news, Natural News

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
The five biggest lies about Ebola being pushed by government and mass media
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
Biologist explains how marijuana causes tumor cells to commit suicide
Companies begin planting microchips under employees' skin
The best way to help your body protect itself against Ebola (or any virus or bacteria)
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
Top ten things you need to do NOW to protect yourself from an uncontrolled Ebola outbreak
Chemotherapy kills cancer patients faster than no treatment at all
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
Why flu shots are the greatest medical fraud in history
Governments seize colloidal silver being used to treat Ebola patients, says advocate
Flu vaccine kills 13 in Italy; death toll rises

Delicious
(NaturalNews) Canada's government health agency, Health Canada, has announced the withdrawal of market authorization for non-steroidal anti-inflammatory lumiracoxib due to evidence connecting the drug to severe liver damage.

Health Canada requested that Novartis stop selling lumiracoxib, marketed as Prexige, and the company has complied with the request.

Prexige is used primarily to treat osteoarthritis patients, and has been approved for sale in 21 countries. The drug's troubles began in August when the Therapeutic Goods Administration of Australia withdrew its approval for Prexige after reviewing evidence on 8 reports of severe liver damage arising from use of the drug. This included two deaths and two liver transplants. Following Australia's decision, New Zealand also pulled the drug from the market.

According to Health Canada, there have been two confirmed cases of liver-related complications from Prexige in Canada. The agency reviewed additional safety information provided by Novartis, and concluded that "the risk of serious hepatotoxicity associated with the use of Prexige cannot be safely and effectively managed."

Health Canada advised all doctors and pharmacists to discontinue prescribing Prexige, return all samples, and discuss new treatment options with patients currently on the drug. It encouraged patients to return any supplies of the drug to their pharmacists. "In order to avoid contaminating ground or municipal water systems, the product should not be flushed down the toilet or sink," Health Canada said.

In 2003, the U.S. FDA rejected the trade name "Prexige" for lumiracoxib. The agency has not yet ruled on whether to approve the drug for use and sale in the United States. Likewise, it has not yet been revealed what trade name the drug would use if approved, although "Prexede" has been suggested.

Countries in which Prexige is still approved for use include Argentina, Brazil, Mexico, South Africa and all European Union countries.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.